Graves’ Disease during Immune Checkpoint Inhibitor Therapy (A Case Series and Literature Review)

SIMPLE SUMMARY: Immune checkpoint inhibitor (ICPi)-induced thyroid dysfunction is a frequent immune-related adverse event (irAE). ICPi-induced thyrotoxicosis is usually the first stage of a biphasic thyroiditis with secondary hypothyroidism, whereas ICPi-induced Graves’ disease (GD), due to the stim...

Descripción completa

Detalles Bibliográficos
Autores principales: Peiffert, Mathilde, Cugnet-Anceau, Christine, Dalle, Stephane, Chikh, Karim, Assaad, Souad, Disse, Emmanuel, Raverot, Gérald, Borson-Chazot, Françoise, Abeillon-du Payrat, Juliette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073133/
https://www.ncbi.nlm.nih.gov/pubmed/33920721
http://dx.doi.org/10.3390/cancers13081944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073133/
https://www.ncbi.nlm.nih.gov/pubmed/33920721
http://dx.doi.org/10.3390/cancers13081944

Ejemplares similares